The Government of Canada today (April 24, 2014) announced the creation of the Canadian Clinical Trials Coordinating Centre (CCTCC) – a collaborative effort of the Canadian Institutes of Health Research (CIHR), Canada’s Research-Based Pharmaceutical Companies (Rx&D), and the merged organizations of the Association of Canadian Academic Healthcare Organizations and the Canadian Healthcare Association (ACAHO/CHA). The CCTCC will be housed at the offices of the Health Charities Coalition of Canada, in Ottawa.
Clinical trials involve testing new therapies with patients. They are a critical step toward bringing new medicines, effective vaccines, and innovative medical devices safely to market. They can result in better medical treatments, better quality of life, cost savings to Canada’s health system, new jobs, and revenue for the Canadian economy. Most importantly, clinical trials have the potential to relieve pain and suffering, and to reverse or halt the effects of disease or disability for Canadian patients.
The CCTCC will improve the coordination of clinical trial activities and streamline regulatory processes for companies and researchers. This will be achieved by implementing the recommendations produced by an extensive stakeholder consultation. Those recommendations were summarized in the report To Your Health and Prosperity – An Action Plan to Help Attract More Clinical Trials to Canada.
The Government of Canada also announced the appointment of Belinda Vandersluis as the organization’s Director of Implementation. Ms. Vandersluis brings to the CCTCC senior leadership experience in clinical trials research administration, an understanding of the complexities of conducting clinical trials in Canada and internationally, and longstanding ties to the clinical trials community.
Access the full press release here.